《大行報告》招商證券上調小鵬汽車(09868.HK)目標價至110元 與滴滴合作解決規模化難題
招商證券發表報告指,小鵬汽車(09868.HK)8月交付量1.4萬輛,按年升42.9%、按月升24.4%,連續七個月實現按月增長,亦連續兩個月交付逾萬輛,其中G6開始交付45日,已實現交付量過萬輛。在8月,銷量過萬的新勢力車企共8間,其中小鵬的按月增速最高。
該行認為,小鵬與滴滴的戰略合作具有互補作用,參與出行領域有利推動銷量,解決電動車規模化的問題,降低整體成本,提升規模效益。
該行預期,G6產銷量持續提升,以及其他改款車型G9及P7i等陸續推出,令公司基本面持續改善,將目標價由96元上調至110元,評級「增持」。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.